Novartis AG
BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS

Abstract:

The present invention provides a compound of formula (1) or a pharmaceutically acceptable salt thereof; ##STR00001## a method for manufacturing said compound, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition comprising said compound.